What Happened?
, -based PTC Therapeutics Appointed Pierre Gravier as Chief Financial Officer
About the Company
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC`s ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
About the Person
Pierre Gravier is Chief Financial Officer at PTC Therapeutics. Previously, Pierre held various senior HR leadership roles in the industry.
Info Source
News
Short Profile